Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.31% | 163.36 | 0.7% | $1395.05m | |
| PFE | Pfizer Inc. | -0.03% | 33.79 | 0.9% | $1240.93m | |
| BMY | Bristol-Myers Squibb Co. | -0.47% | 61.76 | 1.0% | $871.78m | |
| MRK | Merck & Co., Inc. | -0.04% | 74.55 | 0.7% | $835.06m | |
| ABBV | AbbVie, Inc. | -0.09% | 107.30 | 1.9% | $808.30m | |
| LLY | Eli Lilly & Co. | -0.32% | 203.04 | 1.1% | $779.17m | |
| AZN | AstraZeneca Plc | 0.59% | 49.20 | 1.2% | $523.20m | |
| GSK | GlaxoSmithKline Plc | -0.38% | 34.25 | 0.2% | $269.38m | |
| NVS | Novartis AG | 0.77% | 87.44 | 0.2% | $192.32m | |
| SNY | Sanofi | 1.22% | 46.36 | 0.2% | $170.49m | |
| VTRS | Viatris, Inc. | -1.53% | 14.82 | 0.0% | $142.10m | |
| VERU | Veru, Inc. | -3.29% | 13.81 | 0.0% | $115.05m | |
| CVAC | CureVac NV | 1.33% | 94.21 | 0.0% | $107.67m | |
| VYNE | VYNE Therapeutics, Inc. | -1.90% | 7.74 | 0.0% | $98.29m | |
| NVO | Novo Nordisk A/S | 0.15% | 72.45 | 0.1% | $93.17m |
Company Profile
Anacor Pharmaceuticals is a biopharmaceutical company that engages in developing small-molecule therapeutics from its boron chemistry platform. It focuses on developing topical applications of its compounds to treat fungal, bacterial, and inflammatory diseases. The company’s primary product candidate, AN2690, is a novel topical antifungal for the treatment of toenail onychomycosis, a fungal infection of the nail and nail bed. It is also developing AN2728, an anti-inflammatory product candidate for the treatment of psoriasis; AN0128, a product candidate that has antibiotic and anti-inflammatory properties; and AN2718, which is in preclinical development for the topical treatment of vaginal candidiasis and tineapedis.